Goldman JG

References (3)

Title : Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials - Goldman_2020_Alzheimers.Res.Ther_12_137
Author(s) : Goldman JG , Forsberg LK , Boeve BF , Armstrong MJ , Irwin DJ , Ferman TJ , Galasko D , Galvin JE , Kaufer D , Leverenz J , Lippa CF , Marder K , Abler V , Biglan K , Irizarry M , Keller B , Munsie L , Nakagawa M , Taylor A , Graham T
Ref : Alzheimers Res Ther , 12 :137 , 2020
Abstract : Goldman_2020_Alzheimers.Res.Ther_12_137
ESTHER : Goldman_2020_Alzheimers.Res.Ther_12_137
PubMedSearch : Goldman_2020_Alzheimers.Res.Ther_12_137
PubMedID: 33121510

Title : Advances in the treatment of cognitive impairment in Parkinson's disease - Goldman_2015_Mov.Disord_30_1471
Author(s) : Goldman JG , Weintraub D
Ref : Movement Disorders , 30 :1471 , 2015
Abstract : Goldman_2015_Mov.Disord_30_1471
ESTHER : Goldman_2015_Mov.Disord_30_1471
PubMedSearch : Goldman_2015_Mov.Disord_30_1471
PubMedID: 26297863

Title : Treatment of psychosis and dementia in Parkinson's disease - Goldman_2014_Curr.Treat.Options.Neurol_16_281
Author(s) : Goldman JG , Holden S
Ref : Curr Treat Options Neurol , 16 :281 , 2014
Abstract : Goldman_2014_Curr.Treat.Options.Neurol_16_281
ESTHER : Goldman_2014_Curr.Treat.Options.Neurol_16_281
PubMedSearch : Goldman_2014_Curr.Treat.Options.Neurol_16_281
PubMedID: 24464490